| 000 | 01506 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517153650.0 | ||
| 264 | 0 | _c20180417 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1096-0295 | ||
| 024 | 7 |
_a10.1016/j.yrtph.2017.05.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoineau, Sonia | |
| 245 | 0 | 0 |
_aProarrhythmic risk assessment using conventional and new in vitro assays. _h[electronic resource] |
| 260 |
_bRegulatory toxicology and pharmacology : RTP _cAug 2017 |
||
| 300 |
_a1-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtoxicity |
| 650 | 0 | 4 |
_aArsenic _xtoxicity |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aFluoroquinolones _xtoxicity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 | _aMoxifloxacin |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPentamidine _xadministration & dosage |
| 650 | 0 | 4 |
_aPhenethylamines _xtoxicity |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSulfonamides _xtoxicity |
| 700 | 1 | _aCastagné, Vincent | |
| 773 | 0 |
_tRegulatory toxicology and pharmacology : RTP _gvol. 88 _gp. 1-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yrtph.2017.05.012 _zAvailable from publisher's website |
| 999 |
_c27175921 _d27175921 |
||